Posted on 9/4/18
OncoSec Raises $15M From Alpha Holdings
OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today announced that it has secured a $15 million
Posted on 9/4/18
Celgene Vs. AbbVie: The 2 Cheapest Large Cap Pharma Stocks
SummaryFor 2018, both Celgene and AbbVie expect approximately 15% revenue growth.Both Celgene and AbbVie have low PEG ratios of 0.54x and 0.76x, respectively.Wall Street is more . . .
Posted on 9/4/18
Amneal Announces Partnership with American Regent on Generic Makena
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a specialty pharmaceutical company, today announced a 5-year supply and distribution agreement with American Regent for the only preservative-free generic alternative . . .
Posted on 9/3/18
8 of the top 15 Ranked Hospitals Utilize CipherHealth Technology
New York, NY, Aug. 31, 2018 (GLOBE NEWSWIRE) -- U.S. News & World Report just released it’s Best Hospitals rankings for 2018- 2019. Among the esteemed . . .
Posted on 8/31/18
Bioasis Announces Stock Option Grants
GUILFORD, Conn.--(BUSINESS WIRE)--BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a biopharmaceutical company developing its xB3 TM proprietary platform technology for the delivery of therapeutics across the blood-brain barrier . . .
Posted on 8/31/18
Better Buy: Johnson & Johnson vs. Merck
Few industries have the breadth that investors can find in healthcare. Those with a speculative bent can choose drug developers with no sales and only the . . .
Posted on 8/31/18
Capital Health Regional Medical Center Recognized as Top Hospital for Neurology and Neurosurgery
Capital Health Regional Medical Center (RMC), was recently recognized as the best hospital for Neurology and Neurosurgery in the Region in U.S. News & World Report . . .
Posted on 8/30/18
Otsuka Announces First Collaboration Agreement
PRINCETON, N.J.--(BUSINESS WIRE)--Otsuka America Pharmaceutical, Inc. (Otsuka) announced today that it has signed a Collaboration Agreement to facilitate access to the ABILIFY MYCITE System to select . . .
Posted on 8/30/18
Ferring and Celmatix Launch Ambitious Genomics Collaboration
SAINT-PREX, Switzerland & NEW YORK--(BUSINESS WIRE)--Ferring Pharmaceuticals and Celmatix today announced an ambitious genomics collaboration aimed at uncovering new insights into ovarian biology and accelerating the . . .
Posted on 8/30/18
Is Celgene Corporation a Buy?
It's best that I acknowledge that right out of the gate. I've owned Celgene Corporation(NASDAQ:CELG) stock for several years. I've seen it go up, and I've . . .
Posted on 8/29/18
Alliance HealthCare Radiology Finalizes Partnership with Northeast Radiology
IRVINE, Calif.--(BUSINESS WIRE)--Alliance HealthCare Services, Inc. today announces our partnership with Northeast Radiology and welcomes Northeast Radiology into its Alliance HealthCare Radiology division. A national leader . . .
Posted on 8/29/18
Pfizer (PFE) Investor Presentation - Slideshow
The following slide deck was published by Pfizer Inc. in conjunction with this event. 117READ FULL ARTICLE HERE
Posted on 8/29/18
Johnson & Johnson (JNJ) Updates on Mariner & Commander HF Clinical Trial Results - Slideshow
The following slide deck was published by Johnson & Johnson in conjunction with this event. 124READ FULL ARTICLE HERE
Posted on 8/29/18
Pfizer Achieves Success In Rare Heart Disease Study
SummaryPfizer obtains positive results in a phase 3 study treating patients with Transthyretin Cardiomyopathy using Tafamidis.Patients treated with Tafamidis were able to reduce the risk of . . .
Posted on 8/29/18
Pfizer's Tafamidis Will Be Standard Of Care For A Not-So-Rare Disease
SummaryDrugs that are shown to improve survival quickly become standard of care.Tafamidis is the only drug known to improve survival in transthyretin-related (TTR) cardiac amyloidosis and . . .
Posted on 8/29/18
Johnson & Johnson Is Hiring -- and It's Ginormous News for Geron
It's possible that a new job posting has never been as important to a small biotech as this one. And it's highly probable that no reference . . .
Posted on 8/29/18
6 Things Alnylam Investors Need to Know About Pfizer's Next Blockbuster Drug
After 16 years as a public company, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) finally got the go-ahead to launch its first product earlier this month. Onpattro is the . . .
Posted on 8/29/18
Mesoblast Provides Update on Transaction With Tasly Pharmaceutical Group
NEW YORK and MELBOURNE, Australia, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; Nasdaq: MESO) today announced that Tasly Pharmaceutical Group has received People's . . .
Posted on 8/28/18
CitiusTech Makes Strategic Investment in FluidEdge Consulting
PRINCETON, N.J.--(BUSINESS WIRE)--CitiusTech, a leading provider of healthcare technology solutions and services, announced today that it has made a strategic investment in FluidEdge Consulting (FluidEdge), a . . .
Posted on 8/28/18
Biotech Analysis Central Pharma News: J&J And Bayer Failure, Gilead Sciences Unloads Cancer Drug, Mallinckrodt Fails To Get Green Light
SummaryJ&J and Bayer fail to improve prospects for blood clot drug after trial results.Gilead Sciences offloads late-stage drug for myelofibrosis.Mallinckrodt suffers huge blow as FDA rejects . . .
Posted on 8/28/18
Y-mAbs Therapeutics Aims For $92 Million IPO
SummaryY-mAbs Therapeutics has filed to raise $92 million in an IPO from the sale of its common stock.The firm is advancing a large pipeline of antibody-based . . .
Posted on 8/27/18
Enzo Biochem to Acquire New Facility for Manufacturing and Distribution
NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostic and therapeutics company, announced today that, as part of implementing its growth strategy, it has entered into . . .
Posted on 8/27/18
Magnolia Neurosciences Corporation Announces that its Subsidiary Receives $20 Million CPRIT Grant
NEW YORK & HOUSTON--(BUSINESS WIRE)--Magnolia Neurosciences Corporation (Magnolia) today announced that Korysso Therapeutics, Inc. (DBA:Magnolia Tejas Corporation), the company’s wholly owned, Houston-based subsidiary, has been awarded . . .
Posted on 8/27/18
Better Buy: Intuitive Surgical, Inc. vs. Johnson & Johnson
At first glance, Intuitive Surgical (NASDAQ:ISRG) and Johnson & Johnson (NYSE:JNJ)might seem to have little in common other than they both sell medical instruments. However, Johnson . . .
Posted on 8/26/18
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on August 22, 2018 it approved non-statutory stock options to purchase an aggregate of 381,500 shares of its . . .

